Pheton Holdings Net Worth 2023-2024 | PTHL
Interactive chart of historical net worth (market cap) for Pheton Holdings (PTHL) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Pheton Holdings net worth as of January 09, 2026 is $0B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.373B | 30.92 |
| HCA Healthcare (HCA) | United States | $107.724B | 17.83 |
| CVS Health (CVS) | United States | $101.935B | 11.72 |
| Elevance Health (ELV) | United States | $82.857B | 12.15 |
| Cencora (COR) | United States | $65.122B | 20.99 |
| Natera (NTRA) | United States | $32.410B | 0.00 |
| DiDi Global (DIDIY) | China | $24.285B | 22.43 |
| Labcorp Holdings (LH) | United States | $20.875B | 15.92 |
| Medpace Holdings (MEDP) | United States | $16.760B | 41.61 |
| BioMerieux (BMXMF) | France | $15.630B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.207B | 0.00 |
| Solventum (SOLV) | United States | $14.941B | 14.50 |
| Viatris (VTRS) | United States | $14.697B | 5.48 |
| ICON (ICLR) | Ireland | $14.648B | 14.53 |
| Revvity (RVTY) | United States | $11.840B | 21.80 |
| CochLear (CHEOY) | Australia | $11.530B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.872B | 20.94 |
| Avantor (AVTR) | United States | $8.461B | 12.93 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.044B | 0.00 |
| HealthEquity (HQY) | United States | $8.044B | 30.08 |
| Sonic Healthcare (SKHHY) | Australia | $7.443B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.769B | 40.35 |
| PACS (PACS) | United States | $6.464B | 39.31 |
| Bausch + Lomb (BLCO) | Canada | $6.096B | 40.02 |
| Sotera Health (SHC) | United States | $5.455B | 26.30 |
| Alignment Healthcare (ALHC) | United States | $4.158B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.913B | 68.72 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| Concentras Parent (CON) | United States | $2.551B | 15.92 |
| Progyny (PGNY) | United States | $2.327B | 45.75 |
| Organon (OGN) | United States | $2.093B | 2.21 |
| Surgery Partners (SGRY) | United States | $2.085B | 26.87 |
| Establishment Labs Holdings (ESTA) | United States | $1.986B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.919B | 11.46 |
| Teladoc Health (TDOC) | United States | $1.324B | 0.00 |
| Nutex Health (NUTX) | United States | $1.317B | 10.07 |
| Ardent Health (ARDT) | United States | $1.270B | 4.14 |
| GoodRx Holdings (GDRX) | United States | $0.950B | 15.56 |
| Omada Health (OMDA) | United States | $0.892B | 0.00 |
| CareDx (CDNA) | United States | $0.881B | 14.40 |
| Embecta (EMBC) | United States | $0.756B | 4.30 |
| InnovAge Holding (INNV) | United States | $0.719B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.693B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.606B | 0.00 |
| CryoPort (CYRX) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.505B | 22.66 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.491B | 0.00 |
| SBC Medicals (SBC) | United States | $0.455B | 8.38 |
| Agilon Health (AGL) | United States | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.411B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.361B | 5.81 |
| QDM (QDMI) | Hong Kong, SAR China | $0.358B | 75.29 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| KindlyMD (NAKA) | United States | $0.188B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.142B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| Pomdoctor - (POM) | China | $0.032B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Intelligent Bio Solutions (INBS) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |